These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31310373)

  • 1. Molecular docking studies of chloroquine and its derivatives against P23
    Kumar M; Topno RK; Dikhit MR; Bhawana ; Sahoo GC; Madhukar M; Pandey K; Das P
    J Cell Biochem; 2019 Oct; 120(10):18298-18308. PubMed ID: 31310373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment.
    Hasan MA; Khan MA; Datta A; Mazumder MH; Hossain MU
    Mol Immunol; 2015 May; 65(1):189-204. PubMed ID: 25682054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein.
    Ozden S; Lucas-Hourani M; Ceccaldi PE; Basak A; Valentine M; Benjannet S; Hamelin J; Jacob Y; Mamchaoui K; Mouly V; Desprès P; Gessain A; Butler-Browne G; Chrétien M; Tangy F; Vidalain PO; Seidah NG
    J Biol Chem; 2008 Aug; 283(32):21899-908. PubMed ID: 18559340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?
    Shimizu JF; Martins DOS; McPhillie MJ; Roberts GC; Zothner C; Merits A; Harris M; Jardim ACG
    Acta Trop; 2020 Jul; 207():105490. PubMed ID: 32333884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication.
    Rasool N; Bakht A; Hussain W
    Curr Drug Discov Technol; 2021; 18(3):437-450. PubMed ID: 32164512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
    Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus.
    Saha A; Bhagyawant SS; Parida M; Dash PK
    Antiviral Res; 2016 Oct; 134():42-49. PubMed ID: 27565991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function insights into chikungunya virus capsid protein: Small molecules targeting capsid hydrophobic pocket.
    Sharma R; Kesari P; Kumar P; Tomar S
    Virology; 2018 Feb; 515():223-234. PubMed ID: 29306785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
    Roques P; Thiberville SD; Dupuis-Maguiraga L; Lum FM; Labadie K; Martinon F; Gras G; Lebon P; Ng LFP; de Lamballerie X; Le Grand R
    Viruses; 2018 May; 10(5):. PubMed ID: 29772762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
    Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationship of Chikungunya nsP2 protease: A comparative study with papain.
    Ramakrishnan C; Kutumbarao NHV; Suhitha S; Velmurugan D
    Chem Biol Drug Des; 2017 May; 89(5):772-782. PubMed ID: 28054451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of novobiocin and telmisartan for anti-CHIKV activity.
    Tripathi PK; Soni A; Singh Yadav SP; Kumar A; Gaurav N; Raghavendhar S; Sharma P; Sunil S; Ashish ; Jayaram B; Patel AK
    Virology; 2020 Sep; 548():250-260. PubMed ID: 32791353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 20. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.